Rhinitis and sleep apnea

Staevska, Maria; Mandajieva, Mariana; Dimitrov, Vasil

doi:10.1007/s11882-004-0026-0

Cited by 36 publications

(23 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Half of the subjects in the present study indicated a history of allergic rhinitis and having experienced frequent nasal symptoms in the past year. Disorders of the upper respiratory tract may increase the risk and severity of OSAS [30,31] and, similarly, may contribute to the development of adverse symptoms with nCPAP [32]. Furthermore, the present authors administered the questionnaire immediately following nCPAP, which may have led to a higher rate of positive response compared with studies that have relied on patient recall over a period of time.…”

Section: Discussionmentioning

confidence: 97%

Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome

Duong

Jayaram

Camfferman³

et al. 2005

Eur Respir J

View full text Add to dashboard Cite

Nasal symptoms associated with the use of nasal continuous positive airway pressure (nCPAP) in obstructive sleep apnoea (OSA) can adversely impact on patients' tolerance, acceptance and adherence to nCPAP therapy. Regular use of heated humidification is effective in alleviating these symptoms and improve patient comfort.In a randomised, parallel, double-blinded, controlled study, the present authors examined the use of heated humidification during a single night laboratory nCPAP titration in untreated OSA patients and its effect on nasal symptoms, nasal airway resistance (NAR), effective pressure and treatment tolerability and acceptance.Baseline characteristics of subjects (n570) receiving placebo and humidification were (mean¡SEM): age 51.2¡2.2 versus 50.6¡1.6 yrs; body mass index 33.6¡0.9 versus 35.2¡0.9 kg?m significantly different between the groups. No difference was found in the frequency and severity of nasopharyngeal symptoms, therapeutic pressure and subjective response to nCPAP.In conclusion, heated humidification during the initial nasal continuous positive airway pressure titration offers no additional benefit in nasal physiology, symptoms or subjective response to nasal continuous positive airway pressure, and, therefore, should not be routinely recommended.

show abstract

Section: Discussionmentioning

confidence: 97%

Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome

Duong

Jayaram

Camfferman³

et al. 2005

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…The symptoms of ARin particular nasal congestion-adversely affect sleep, and the degree of sleep impairment is used in the Allergic Rhinitis and its Impact on Asthma guidelines to classify AR severity [4••]. Sleep disturbances associated with AR include sleep-disordered breathing (ranging from snoring to obstructive sleep apnea [OSA] and/or hypopnea) and microarousals [11][12][13], although one study suggested that AR is not a major risk factor for OSA syndrome [14].…”

Section: Evidence Of Sleep Impairmentmentioning

confidence: 99%

Congestion and Sleep Impairment in Allergic Rhinitis

Craig

Sherkat

Safaee

2010

Curr Allergy Asthma Rep

View full text Add to dashboard Cite

Allergic rhinitis is a prevalent disease in developed nations, and its prevalence has been increasing throughout the world. Nasal congestion is the most common and bothersome symptoms of rhinitis. Congestion is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

show abstract

“…[26][27][28] Therefore, the nasal congestion associated with AR can limit maximal upper airway airflow and contribute to sleep disturbances. 29 Specific types of sleep disturbances or sleep-disordered breathing (SDB) related to increased airway resistance include snoring, upper airway resistance syndrome, and obstructive sleep apnoea syndrome. Snoring is associated with changes in the calibre of the upper airway which reduce flow and increase airway resistance, and is a manifestation of increased turbulence in nasal flow.…”

Section: Mechanisms Of Nasal Congestion: Impact On Sleep Quality and mentioning

confidence: 99%

“…Obstructive sleep apnoea syndrome is associated with sleep fragmentation and excessive daytime sleepiness, neuropsychiatric complications (e.g., sleepiness, depression, and cognitive dysfunction), and cardiovascular complications -including pulmonary and systemic hypertension, congestive heart failure, myocardial infarction, and stroke. 29,31 Allergic rhinitis-associated nasal congestion results from dilation of venous capacitance vessels in the nasal submucosa and increased vascular permeability, mucosal oedema with influx of inflammatory cells, and excess secretions. 26 The allergic response is composed of two phases: the early phase and late phase.…”

Section: Mechanisms Of Nasal Congestion: Impact On Sleep Quality and mentioning

confidence: 99%

Allergic rhinitis-induced nasal congestion: its impact on sleep quality

Storms¹

2008

Primary Care Respiratory Journal

View full text Add to dashboard Cite

Allergic rhinitis (AR) is an extremely common health problem affecting 20 to 40 million Americans and between 10-25% of the world's population. Patients with AR suffer from both nasal symptoms (congestion, rhinorrhea, itching, and sneezing) and ocular symptoms (itching, redness, and tearing). The negative impact on sleep quality and quantity, and consequently on various aspects of the patient's life, is an under-recognised and under-treated component of AR morbidity. Nasal congestion, which is one of the most bothersome and prevalent symptoms of AR, is thought to be the leading symptom responsible for rhinitis-related sleep problems.In addition to reducing clinical symptoms, pharmacologic therapies for AR that specifically reduce inflammatory cells and mediators -and therefore nasal congestion and other symptoms -should also improve sleep quality and overall quality of life (QOL). Intranasal corticosteroids (INS) are the current mainstay of therapy for AR. Results of a number of clinical trials demonstrate that INS effectively reduce nasal congestion and ocular symptoms, improve sleep quality, and decrease daytime somnolence. Intranasal corticosteroids have also proved to be effective in reducing symptoms of acute rhinosinusitis and nasal polyposis, both of which also negatively impact on sleep quality. Intranasal corticosteroids are considered safe due to their low systemic bioavailability.

show abstract

Rhinitis and sleep apnea

Cited by 36 publications

References 48 publications

Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome

Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome

Congestion and Sleep Impairment in Allergic Rhinitis

Allergic rhinitis-induced nasal congestion: its impact on sleep quality

Contact Info

Product

Resources

About